Patent application number | Description | Published |
20090015256 | Optimized MRI strip array detectors and apparatus, systems and methods related thereto - Featured is a device for NMR or MRI signals from excited nuclei as well as related apparatus, systems and methods. The device includes a strip array antenna including one or more conductor and N reactive tuning components, where N is an integer ≧1 at least one of the N reactive components is electrically coupled to each of the one or more conductors as well as to ground/virtual ground. The apparent electrical length of the conductors is tuned with the reactive tuning components so it is equal to be about nλ/4, where n is an integer ≧1 and λ is the wavelength of the signal to be detected. The length of the strip also is such as to be substantially in the approximate range of 1.3 times the depth of interest. The strip conductors are also combined with loop coils to form quadrature detectors. | 01-15-2009 |
20110037468 | OPTIMIZED MRI STRIP ARRAY DETECTORS AND APPARATUS, SYSTEMS AND METHODS RELATED THERETO - Featured is a device for NMR or MRI signals from excited nuclei as well as related apparatus, systems and methods. The device includes a strip array antenna including one or more conductor and N reactive tuning components, where N is an integer≧1 at least one of the N reactive components is electrically coupled to each of the one or more conductors as well as to ground/virtual ground. The apparent electrical length of the conductors is tuned with the reactive tuning components so it is equal to be about nλ/4, where n is an integer≧1 and λ is the wavelength of the signal to be detected. The length of the strip also is such as to be substantially in the approximate range of 1.3 times the depth of interest. The strip conductors are also combined with loop coils to form quadrature detectors. | 02-17-2011 |
20120265000 | Systems and Methods to Reduce Power Deposition in Tissue Exposed to Radio Frequency Electromagnetic Fields - An apparatus for exposing a region of interest of an object, animal or person to an alternating magnetic field has a source of radio-frequency electromagnetic radiation arranged to provide the alternating magnetic field in an exposure volume defined by the apparatus, and a shield arranged between the source of radio-frequency electromagnetic radiation and the exposure volume. The shield includes a material that has a sufficient thickness and arrangement to reduce power deposition to at least regions outside of the region of interest of the object, animal or person during exposure in the exposure volume. | 10-18-2012 |
Patent application number | Description | Published |
20140096164 | ENHANCED USER EXPERIENCE FOR MIRACAST DEVICES - A method is implementable in a source device that is operable to provide, via a wireless channel, a video stream to a sink device for display by the sink device. The method includes receiving compressed video data corresponding to one or more video frames of the video stream, and generating a current packet of a plurality of packets. The plurality of packets collectively includes the compressed video data. The current packet includes a current portion of the compressed video data and recovery information indicative of at least one of (i) an arrangement of an earlier portion of the compressed video data, or (ii) content of the earlier portion of the compressed video data, wherein the earlier portion of the compressed video data is data included in an earlier packet of the plurality of packets. The method also includes causing the current packet to be transmitted to the sink device. | 04-03-2014 |
20140096165 | ENHANCED USER EXPERIENCE FOR MIRACAST DEVICES - A method is implementable in a source device operable to provide, via a wireless channel, a video stream to a sink device for display by the sink device. The method includes receiving link quality information indicative of a condition of the wireless channel and/or performance of communications between the source device and the sink device via the wireless channel. The method also includes determining a measure of network congestion based on the link quality information, and, based on the measure of network congestion, skipping one or more, but not all, video frames of a plurality of video frames in the video stream, such that the one or more video frames are not provided to the sink device, reconfiguring a video encoder operating on the plurality of video frames, such that an output bit rate of the video encoder is changed, and/or changing a video format of the video stream. | 04-03-2014 |
Patent application number | Description | Published |
20090134065 | Pentasil Catalyst for Light Olefins in Fluidized Catalytic Units - The catalyst of this invention is capable of enhancing light olefin, e.g., propylene, yields in fluidizable catalytic cracking (FCC) processes. The catalyst comprises (a) pentasil zeolite, (b) at least 5% by weight phosphorus (P | 05-28-2009 |
20100010279 | Catalyst Compositions Comprising Metal Phosphate Bound Zeolite and Methods of Using Same to Catalytically Crack Hydrocarbons - A catalyst composition comprising metal phosphate binder and zeolite can be used to enhance olefin yields during hydrocarbon cracking processes. The composition typically further comprises aluminum phosphate, and the metal of the metal phosphate is a metal other than aluminum. Depending on the metal chosen, enhanced propylene and isobutylene yields in fluid catalytic cracking processes can be obtained compared to catalysts that do not contain such metal phosphate binders. The catalyst can also comprise non-zeolitic molecular sieves, thereby making the composition suitable for use in areas outside of catalytic cracking, e.g., purification and adsorbent applications. | 01-14-2010 |
20100252484 | PROCESS FOR PREPARING HIGH ATTRITION RESISTANT INORGANIC COMPOSITIONS AND COMPOSITIONS PREPARED THEREFROM - A process for the production of high attrition resistant inorganic compositions is provided. The formation of highly attrition resistant compositions is accomplished by forming a slurry of inorganic components, a binder, and optionally clay and matrix materials, milling the slurry, and cooling the milled slurry to a temperature below 17° C., preferably below 10° C. The cooled slurry is subjected to spray-drying, and optionally calcining and/or washing, to provide highly attrition resistant inorganic particles. Catalytic cracking catalysts formed by the process are also disclosed. | 10-07-2010 |
20100264066 | Aluminum sulfate bound catalysts - Alumina binder obtained from aluminum sulfate, the process of preparing the binder and the process of using the binder to prepare catalyst compositions are disclosed. Catalytic cracking catalyst compositions, in particularly, fluid catalytic cracking catalyst composition comprising zeolites, optionally clay and matrix materials bound by an alumina binder obtained from aluminum sulfate are disclosed. | 10-21-2010 |
20110017640 | RARE EARTH CARBONATE COMPOSITIONS FOR METALS TOLERANCE IN CRACKING CATALYSTS - This is invention is a composition comprising discrete particles that comprise rare earth carbonate, preferably lanthanum carbonate, dispersed in a matrix. The composition may be combined with zeolite-containing cracking catalysts to enhance catalytic activity and/or selectivity in the presence of metals (Ni and V). | 01-27-2011 |
20110036754 | CATALYTIC CRACKING CATALYST COMPOSITIONS HAVING IMPROVED BOTTOMS CONVERSION - A particulate catalytic cracking catalyst which comprises a zeolite having catalytic cracking ability under catalytic cracking conditions, added silica, precipitated alumina and, optionally clay. The catalytic cracking catalyst has a high matrix surface area and is useful in a catalytic cracking process, in particularly, a fluid catalytic cracking process, to improve bottoms conversion at a constant coke formation. | 02-17-2011 |
20140021097 | SILICA SOL BOUND CATALYTIC CRACKING CATALYST STABILIZED WITH MAGNESIUM - A rare earth free particulate catalytic cracking catalyst which comprises a zeolite having catalytic cracking ability under catalytic cracking conditions, an acidified silica sol binder, magnesium salt, clay and a matrix material. The catalytic cracking catalyst has a high matrix surface area and is useful in a catalytic cracking process, in particularly, a fluid catalytic cracking process, to provide increased catalytic activity and improved hydrogen and coke selectivity without the need to incorporate rare earth metals. | 01-23-2014 |
20140021098 | HIGH MATRIX SURFACE AREA CATALYTIC CRACKING CATALYST STABILIZED WITH MAGNESIUM AND SILICA - Particulate catalytic cracking catalysts which comprise a zeolite having catalytic cracking ability under catalytic cracking conditions, added silica, a magnesium salt, an alumina containing binder, clay and optionally, a matrix material. The catalytic cracking catalyst has a high matrix surface area and is useful in a catalytic cracking process, in particularly, a fluid catalytic cracking process, to provide increased catalytic activity and improved coke and hydrogen selectivity without the need to incorporate rare earth metals. | 01-23-2014 |
20140243188 | ALUMINUM SULFATE BOUND CATALYSTS - Alumina binder obtained from aluminum sulfate, the process of preparing the binder and the process of using the binder to prepare catalyst compositions are disclosed. Catalytic cracking catalyst compositions, in particularly, fluid catalytic cracking catalyst composition comprising zeolites, optionally clay and matrix materials bound by an alumina binder obtained from aluminum sulfate are disclosed. | 08-28-2014 |
20150202602 | MAGNESIUM STABILIZED ULTRA LOW SODA CRACKING CATALYSTS - A rare earth free, ultra low soda, particulate fluid catalytic cracking catalyst which comprises a reduced soda zeolite having fluid catalytic cracking ability under fluid catalytic cracking conditions, a magnesium salt, an inorganic binder, clay and optionally, a matrix material. The catalytic cracking catalyst is useful in a fluid catalytic cracking process to provide increased catalytic activity, and improved coke and hydrogen selectivity without the need to incorporate rare earth metals. | 07-23-2015 |
Patent application number | Description | Published |
20130060632 | Methods and Systems for Providing Mobile Advertising Using Data Networks Based On Intelligence Data Associated with Internet-Connectable Devices Derived Using Graph Data Models - Computer systems and methods for providing mobile advertising using data networks based on intelligence data associated with Internet-connectable devices derived using graph data models are provided. In some embodiments, the computer systems and methods may comprise representing Internet-connectable device and associated data as nodes in a graph data model and relationships between the nodes as edges. In some embodiments, the nodes and edges may be traversed to help determine optimal ads to serve the Internet-connectable devices. | 03-07-2013 |
20130060638 | Methods and Systems for Providing Mobile Advertising Using Data Networks Based On Intelligence Data Associated with Internet-Connectable Devices - Computer systems and methods for providing mobile advertising using data networks based on intelligence data associated with Internet-connectable devices are provided. In some embodiments, the computer systems and methods may comprise determining an audience category associated with a user of an Internet-connectable device based on location and/or network events associated with the Internet-connectable device. In these embodiments, an audience value for the user of the Internet-connectable device may be determined based on at least the audience category associated with the user of the Internet-connectable device, wherein the audience value represents an audience segment comprising a subgroup of Internet-connectable device users defined based on at least one criterion. At least one advertisement may then be served to the Internet-connectable device, wherein the at least one advertisement is determined based on the audience value. | 03-07-2013 |
20130060639 | Methods and Systems for Providing Mobile Advertising Using Data Networks Based On Groupings Associated with Internet-Connectable Devices - Computer systems and methods for providing mobile advertising using data networks based on groupings associated with Internet-connectable devices are disclosed. In some embodiments, the computer systems and methods may comprise receiving and/or retrieving events; grouping the events into an events group; determining an audience value for a user of the Internet-connectable device based on the events group, wherein the audience value represents an audience segment comprising a subgroup of Internet-connectable device users defined based on at least one criterion; and transmitting an advertisement to the Internet-connectable device, wherein the advertisement is determined based on the audience value. | 03-07-2013 |
20130060640 | Methods and Systems for Performing Proximity-Based Targeting of Advertisements to Internet-Connectable Devices and Utilizing Predicted Locations of Internet-Connectable Devices Using Data Networks - Computer systems and methods for performing proximity-based targeting of advertisements to Internet-connectable devices and utilizing predicted locations of Internet-connectable devices using data networks are provided. In some embodiments, the computer systems and methods comprise receiving from an Internet-connectable device at least one location event captured by the Internet-connectable device; determining a latest location of the Internet-connectable device based on the at least one location event; determining a proximity of the Internet-connectable device to a campaign location based on the latest location of the Internet-connectable device; and transmitting an advertisement to the Internet-connectable device based on the proximity of the Internet-connectable device to the campaign location. | 03-07-2013 |
20130060921 | Methods and Systems for Capturing and Transmitting Locations Events Data Using Data Networks - Computer systems and methods for efficiently capturing and transmitting location events data using data networks are provided. In some embodiments, the computer systems and methods may comprise detecting an occurrence of a state change event of interest for an Internet-connectable device; determining optimal Internet-connectable device settings for location event captures and/or transmissions performed by the Internet-connectable device based on the detected occurrence of the state change event of interest; adjusting a configuration of the Internet-connectable device based on the determined optimal settings; and capturing and/or transmitting location events based on the adjusted configuration of the Internet-connectable device. | 03-07-2013 |
20130346605 | Methods and Systems for Capturing and Transmitting Locations Events Data Using Data Networks - Computer systems and methods for efficiently capturing and transmitting location events data using data networks are provided. In some embodiments, the computer systems and methods may comprise detecting an occurrence of a state change event of interest for an Internet-connectable device; determining optimal Internet-connectable device settings for location event captures and/or transmissions performed by the Internet-connectable device based on the detected occurrence of the state change event of interest; adjusting a configuration of the Internet-connectable device based on the determined optimal settings; and capturing and/or transmitting location events based on the adjusted configuration of the Internet-connectable device. | 12-26-2013 |
Patent application number | Description | Published |
20140088052 | CHALCONE DERIVATIVES AS NRF2 ACTIVATORS - Compounds and methods for treating or preventing a disease, disorder or condition associated with an Nrf2-regulated pathway, including those associated with an autoimmune disease, comorbidity associated with diabetes, such as retinopathy and nephropathy, bone marrow transplant for leukemia and related cancers, bone marrow deficiencies, inborn errors of metabolism, and other immune disorders, oxidative stress, respiratory infection, ischemia, neurodegenerative disorders, radiation injury, neutropenia caused by chemotherapy, autoimmunity, and congenital neutropenic disorders, and for restoring a corticosteroid responsiveness, in a subject are provided. | 03-27-2014 |
Patent application number | Description | Published |
20110022331 | Assay Information Management Methods and Devices - The present invention relates to methods, devices and systems for associating assay information with an assay consumable used in a biological assay. Provided are assay systems and associated consumables, wherein the assay system includes a reader adapted to read/erase/write information from/to an assay consumable identifier associated with the assay consumable. Various types of assay information are described, as well as methods of using such information in the conduct of an assay by an assay system. | 01-27-2011 |
20110201099 | Assay Cartridges and Methods of Using the Same - Assay cartridges are described that have a detection chamber, preferably having integrated electrodes, and other fluidic components which may include sample chambers, waste chambers, conduits, vents, bubble traps, reagent chambers, dry reagent pill zones and the like. In certain embodiments, these cartridges are adapted to receive and analyze a sample collected on an applicator stick. Also described are kits including such cartridges and a cartridge reader configured to analyze an assay conducted using an assay cartridge. | 08-18-2011 |
20120157332 | Reagent Storage in an Assay Device - The invention relates to methods for conducting binding assays in an assay device that includes one or more storage and use zone. The storage zones of the assay device are configured to house one or more reagents used in an assay conducted in the use zone of the device. | 06-21-2012 |
20120178091 | Assay Cartridges and Methods of Using the Same - Assay cartridges are described that have purification, reaction, and detection zones and other fluidic components which can include sample chambers, waste chambers, conduits, vents, reagent chambers, reconstitution chambers and the like. The assay cartridges are used to conduct multiplexed nucleic acid measurements. Also described are kits including such cartridges, methods of using the same, and a reader configured to analyze an assay conducted using an assay cartridge. | 07-12-2012 |
20120190589 | Assay Cartridges and Methods of Using the Same - Assay cartridges are described that have a detection chamber, preferably having integrated electrodes, and other fluidic components which may include sample chambers, waste chambers, conduits, vents, bubble traps, reagent chambers, dry reagent pill zones and the like. In certain embodiments, these cartridges are adapted to receive and analyze a sample collected on an applicator stick. Also described are kits including such cartridges and a cartridge reader configured to analyze an assay conducted using an assay cartridge. | 07-26-2012 |
20130261016 | DIAGNOSTIC METHODS FOR INFLAMMATORY DISORDERS - The present invention relates to methods of diagnosing an inflammatory disorder in a patient, as well as methods of monitoring the progression of an inflammatory disorder and/or methods of monitoring a treatment protocol of a therapeutic agent or regimen. The invention also relates to assay methods used in connection with the diagnostic methods described herein. | 10-03-2013 |
20130316928 | REAGENT STORAGE IN AN ASSAY DEVICE - The invention relates to methods for conducting binding assays in an assay device that includes one or more storage and use zone. The storage zones of the assay device are configured to house one or more reagents used in an assay conducted in the use zone of the device. | 11-28-2013 |
20140220006 | LUNG CANCER BIOMARKERS - The present invention relates to methods of diagnosing lung cancer in a patient, as well as methods of monitoring the progression of lung cancer and/or methods of monitoring a treatment protocol of a therapeutic agent or a therapeutic regimen. The invention also relates to assay methods used in connection with the diagnostic methods described herein. | 08-07-2014 |
20140256588 | METHODS FOR CONDUCTING MULTIPLEXED ASSAYS - The invention relates to methods for conducting solid-phase binding assays. One example is an assay method having improved analyte specificity where specificity is limited by the presence of non-specific binding interactions. | 09-11-2014 |
20140315742 | BIODOSIMETRY PANELS AND METHODS - The present invention relates to methods and kits to assess an absorbed dose of ionizing radiation and/or the severity of tissue injury from radiation in a patient. The invention also relates to algorithms used to calculate an absorbed dose of radiation based on biomarker measurements of a plurality of biomarkers that are altered relative to a normal control in the event of radiation exposure. | 10-23-2014 |
20150025004 | KIDNEY FUNCTION BIOMARKERS - The present invention relates to methods of diagnosing a kidney disorder in a patient, as well as methods of monitoring the progression of a kidney disorder and/or methods of monitoring a treatment protocol of a therapeutic agent or a therapeutic regimen. The invention also relates to assay methods used in connection with the diagnostic methods described herein. | 01-22-2015 |
20150038365 | LUNG CANCER BIOMARKERS - The present invention relates to methods of diagnosing lung cancer in a patient, as well as methods of monitoring the progression of lung cancer and/or methods of monitoring a treatment protocol of a therapeutic agent or a therapeutic regimen. The invention also relates to assay methods used in connection with the diagnostic methods described herein. | 02-05-2015 |
20150190810 | Assay Cartridge Valve System - Assay cartridges are described that have a plurality of chambers and a fluidic network that includes fluidic conduits and a multi-port valve designed to selectively connect the valve inlet and one valve outlet through a fluidic connector in the valve as the remaining valve outlets are sealed. | 07-09-2015 |
20160003822 | BIODOSIMETRY PANELS AND METHODS - The present invention relates to methods and kits to assess an absorbed dose of ionizing radiation and/or the severity of tissue injury from radiation in a patient. The invention also relates to algorithms used to calculate an absorbed dose of radiation based on biomarker measurements of a plurality of biomarkers that are altered relative to a normal control in the event of radiation exposure. | 01-07-2016 |
Patent application number | Description | Published |
20090246076 | ELECTROCHEMILUMINESCENCE FLOW CELL AND FLOW CELL COMPONENTS - An electrochemiluminescence cell comprising an electrode capable of inducing an electrochemiluminescence-active species to electrochemiluminesce. The electrode is preferably made of rhodium, iridium or an alloy of platinum, rhodium or iridium alloyed with an alloy material comprising a transition element. The electrode may be used as counter electrode and/or as a working electrode in the electrochemiluminescence cell. The cell preferably includes a counter electrode and a support attached to the counter electrode. The support comprises a transparent portion in optical registration with the working electrode. The counter electrode may include one or more field extending elements interposed between the transparent portion and the working electrode. The field extending element is preferably a ladder or a grid. | 10-01-2009 |
20100316992 | DIAGNOSTIC TEST - Disclosed are methods for conducting diagnostic tests for the detection of the inflammatory bowel diseases, such as Crohn's disease and ulcerative colitis. Also described are methods for monitoring a patient by administering tests of the present invention. Also described are methods for monitoring patient's treatment by administering tests of the present invention. Also described are methods for evaluating the effectiveness of a drug or a drug candidate by administering tests of the present invention to samples from patients, animal models, and cell cultures treated with a drug or a drug candidate. Also disclosed are methods for determining the usefulness of analytes, e.g. cytokines, for acting as diagnostic and monitoring markers for inflammatory bowel disease in the various methods of the invention. | 12-16-2010 |
20110015091 | ASSAY MODULES HAVING ASSAY REAGENTS AND METHODS OF MAKING AND USING SAME - We describe assay modules (e.g., assay plates, cartridges, multi-well assay plates, reaction vessels, etc.), processes for their preparation, and method of their use for conducting assays. Reagents may be present in free form or supported on solid phases including the surfaces of compartments (e.g., chambers, channels, flow cells, wells, etc.) in the assay modules or the surface of colloids, beads, or other particulate supports. In particular, dry reagents can be incorporated into the compartments of these assay modules and reconstituted prior to their use in accordance with the assay methods. A desiccant material may be used to maintain and stabilize these reagents in a dry state. | 01-20-2011 |
20120195800 | ASSAY APPARATUSES, METHODS AND REAGENTS - We describe apparatuses, systems, method, reagents, and kits for conducting assays as well as process for their preparation. They are particularly well suited for conducting automated sampling, sample preparation, and analysis in a multi-well plate assay format. For example, they may be used for automated analysis of particulates in air and/or liquid samples derived therefrom in environmental monitoring. | 08-02-2012 |
20130065788 | ASSAY MODULES HAVING ASSAY REAGENTS AND METHODS OF MAKING AND USING SAME - We describe assay modules (e.g., assay plates, cartridges, multi-well assay plates, reaction vessels, etc.), processes for their preparation, and method of their use for conducting assays. Reagents may be present in free form or supported on solid phases including the surfaces of compartments (e.g., chambers, channels, flow cells, wells, etc.) in the assay modules or the surface of colloids, beads, or other particulate supports. In particular, dry reagents can be incorporated into the compartments of these assay modules and reconstituted prior to their use in accordance with the assay methods. A desiccant material may be used to maintain and stabilize these reagents in a dry state. | 03-14-2013 |
20130172431 | DIAGNOSTIC TEST - Disclosed are methods for conducting diagnostic tests for the detection of the inflammatory bowel diseases, such as Crohn's disease and ulcerative colitis. Also described are methods for monitoring a patient by administering tests of the present invention. Also described are methods for monitoring patient's treatment by administering tests of the present invention. Also described are methods for evaluating the effectiveness of a drug or a drug candidate by administering tests of the present invention to samples from patients, animal models, and cell cultures treated with a drug or a drug candidate. Also disclosed are methods for determining the usefulness of analytes, e.g. cytokines, for acting as diagnostic and monitoring markers for inflammatory bowel disease in the various methods of the invention. | 07-04-2013 |
20140378347 | DIAGNOSTIC TEST - Disclosed are methods for conducting diagnostic tests for the detection of the inflammatory bowel diseases, such as Crohn's disease and ulcerative colitis. Also described are methods for monitoring a patient by administering tests of the present invention. Also described are methods for monitoring patient's treatment by administering tests of the present invention. Also described are methods for evaluating the effectiveness of a drug or a drug candidate by administering tests of the present invention to samples from patients, animal models, and cell cultures treated with a drug or a drug candidate. Also disclosed are methods for determining the usefulness of analytes, e.g. cytokines, for acting as diagnostic and monitoring markers for inflammatory bowel disease in the various methods of the invention. | 12-25-2014 |
Patent application number | Description | Published |
20140088052 | CHALCONE DERIVATIVES AS NRF2 ACTIVATORS - Compounds and methods for treating or preventing a disease, disorder or condition associated with an Nrf2-regulated pathway, including those associated with an autoimmune disease, comorbidity associated with diabetes, such as retinopathy and nephropathy, bone marrow transplant for leukemia and related cancers, bone marrow deficiencies, inborn errors of metabolism, and other immune disorders, oxidative stress, respiratory infection, ischemia, neurodegenerative disorders, radiation injury, neutropenia caused by chemotherapy, autoimmunity, and congenital neutropenic disorders, and for restoring a corticosteroid responsiveness, in a subject are provided. | 03-27-2014 |
20140171503 | NUCLEAR RECEPTOR MODULATORS AND THEIR USE FOR THE TREATMENT AND PREVENTION OF CANCER - Disclosed are compounds which are nuclear receptor modulators that can act as antagonists to the androgen receptor, for example, a compound of Formula I: wherein R | 06-19-2014 |